{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:58:23Z","timestamp":1787003903256,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C54674\/A27487"],"award-info":[{"award-number":["C54674\/A27487"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C51061\/A27453"],"award-info":[{"award-number":["C51061\/A27453"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022011","name":"cambridgeuniversity | Cancer Research UK Cambridge Institute, University of Cambridge","doi-asserted-by":"publisher","award":["C9685\/A25117,C9685\/A28397"],"award-info":[{"award-number":["C9685\/A25117,C9685\/A28397"]}],"id":[{"id":"10.13039\/501100022011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI | Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12022\/1 and MC_UU_12022\/8"],"award-info":[{"award-number":["MC_UU_12022\/1 and MC_UU_12022\/8"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI | Medical Research Council","doi-asserted-by":"publisher","award":["MRC_MC_UU_12022\/6"],"award-info":[{"award-number":["MRC_MC_UU_12022\/6"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101135034 (UKRI #10107542)"],"award-info":[{"award-number":["101135034 (UKRI #10107542)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101073507"],"award-info":[{"award-number":["101073507"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"EC | ERC | HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["ERC819920"],"award-info":[{"award-number":["ERC819920"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"UKRI | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J004456\/1,BB\/P013384\/1 and BB\/Y006925\/1"],"award-info":[{"award-number":["BB\/J004456\/1,BB\/P013384\/1 and BB\/Y006925\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations in KRAS, particularly at codon 12, are frequent in adenocarcinomas of the colon, lungs and pancreas, driving carcinogenesis by altering cell signalling and reprogramming metabolism. However, the specific mechanisms by which different KRAS G12 alleles initiate distinctive patterns of metabolic reprogramming are unclear. Using isogenic panels of colorectal cell lines harbouring the G12A, G12C, G12D and G12V heterozygous mutations and employing transcriptomics, metabolomics, and extensive biochemical validation, we characterise distinctive features of each allele. We demonstrate that cells harbouring the common G12D and G12V oncogenic mutations significantly alter glutamine metabolism and nitrogen recycling through FOXO1-mediated regulation compared to parental lines. Moreover, with a combination of small molecule inhibitors targeting glutamine and glutamate metabolism, we also identify a common vulnerability that eliminates mutant cells selectively. These results highlight a previously unreported mutant-specific effect of KRAS alleles on metabolism and signalling that could be potentially harnessed for cancer therapy.<\/jats:p>","DOI":"10.1038\/s44319-025-00641-z","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:25:44Z","timestamp":1763652344000},"page":"142-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["FOXO1 links KRAS G12D and G12V alleles to glutamine and nitrogen metabolism in colorectal cancer"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-6032","authenticated-orcid":false,"given":"Suzan","family":"Ber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sciacovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamith","family":"Samarajiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efterpi","family":"Nikitopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-2672","authenticated-orcid":false,"given":"Ashok R","family":"Venkitaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-7397","authenticated-orcid":false,"given":"Christian","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-091X","authenticated-orcid":false,"given":"Alessandro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"641_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"LA Aaltonen","year":"2020","unstructured":"Aaltonen LA, Abascal F, Abeshouse A, Aburatani H, Adams DJ, Agrawal N, Ahn KS, Ahn S-M, Aikata H, Akbani R et al (2020) Pan-cancer analysis of whole genomes. Nature 578:82\u201393","journal-title":"Nature"},{"key":"641_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cellsig.2006.08.015","volume":"19","author":"S Asada","year":"2007","unstructured":"Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y et al (2007) Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19:519\u2013527","journal-title":"Cell Signal"},{"key":"641_CR3","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M et al (2012) NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res 41:D991\u2013D995","journal-title":"Nucleic Acids Res"},{"key":"641_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15965","volume":"8","author":"DE Biancur","year":"2017","unstructured":"Biancur DE, Paulo JA, Ma\u0142achowska B, Del Rey MQ, Sousa CM, Wang X, Sohn ASW, Chu GC, Gygi SP, Harper JW et al (2017) Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun 8:15965","journal-title":"Nat Commun"},{"key":"641_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.celrep.2019.09.056","volume":"29","author":"AJ Bott","year":"2019","unstructured":"Bott AJ, Shen J, Tonelli C, Zhan L, Sivaram N, Jiang YP, Yu X, Bhatt V, Chiles E, Zhong H et al (2019) Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism. Cell Rep 29:1287\u20131298.e6","journal-title":"Cell Rep"},{"key":"641_CR7","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011\u20132015","journal-title":"Science"},{"key":"641_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","volume":"4","author":"C Cheng","year":"2022","unstructured":"Cheng C, Geng F, Li Z, Zhong Y, Wang H, Cheng X, Zhao Y, Mo X, Horbinski C, Duan W et al (2022) Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nat Metab 4:575\u2013588","journal-title":"Nat Metab"},{"key":"641_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BCJ20210777","volume":"479","author":"Z Cheng","year":"2022","unstructured":"Cheng Z (2022) FoxO transcription factors in mitochondrial homeostasis. Biochem J 479:525\u2013536. https:\/\/doi.org\/10.1042\/BCJ20210777","journal-title":"Biochem J"},{"key":"641_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22125-z","volume":"12","author":"JH Cook","year":"2021","unstructured":"Cook JH, Melloni GEM, Gulhan DC, Park PJ, Haigis KM (2021) The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun 12:1808","journal-title":"Nat Commun"},{"key":"641_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nrd4389","volume":"13","author":"AD Cox","year":"2014","unstructured":"Cox AD, Fesik SW, Kimmelman AC, Luo J, Der CJ (2014) Drugging the undruggable RAS: mission possible?. Nat Rev Drug Discov 13:828\u2013851","journal-title":"Nat Rev Drug Discov"},{"key":"641_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P (2018) Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10:1564","journal-title":"Nutrients"},{"key":"641_CR13","doi-asserted-by":"crossref","unstructured":"Demarco V, Dyess K, Strauss D, West CM, Neu J (1999) Inhibition of Glutamine Synthetase Decreases Proliferation of Cultured Rat Intestinal Epithelial Cells. J Nutr 129:57\u201362","DOI":"10.1093\/jn\/129.1.57"},{"key":"641_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"641_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnaci\u00f3n-Rosado","year":"2024","unstructured":"Encarnaci\u00f3n-Rosado J, Sohn ASW, Biancur DE, Lin EY, Osorio-Vasquez V, Rodrick T, Gonz\u00e1lez-Baerga D, Zhao E, Yokoyama Y, Simeone DM et al (2024) Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer 5:85\u201399","journal-title":"Nat Cancer"},{"key":"641_CR16","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1038\/sj.emboj.7600476","volume":"23","author":"MAG Essers","year":"2004","unstructured":"Essers MAG, Weijzen S, De Vries-Smits AMM, Saarloos I, De Ruiter ND, Bos JL, Burgering BMT (2004) FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23:4802\u20134812","journal-title":"EMBO J"},{"key":"641_CR17","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1128\/MCB.05523-11","volume":"31","author":"X Feng","year":"2011","unstructured":"Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li L, Ganju RK, Shen R, Zou X (2011) Cdc25A regulates Matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells. Mol Cell Biol 31:3457\u20133471","journal-title":"Mol Cell Biol"},{"key":"641_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/msb.2011.56","volume":"7","author":"D Gaglio","year":"2011","unstructured":"Gaglio D, Metallo CM, Gameiro PA, Hiller K, Danna LS, Balestrieri C, Alberghina L, Stephanopoulos G, Chiaradonna F (2011) Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 7:523","journal-title":"Mol Syst Biol"},{"key":"641_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2009.11.013","volume":"290","author":"F Ghoddoussi","year":"2010","unstructured":"Ghoddoussi F, Galloway MP, Jambekar A, Bame M, Needleman R, Brusilow WSA (2010) Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci 290:41\u201347","journal-title":"J Neurol Sci"},{"key":"641_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrc3298","volume":"12","author":"RJ Gillies","year":"2012","unstructured":"Gillies RJ, Verduzco D, Gatenby RA (2012) Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 12:487\u2013493","journal-title":"Nat Rev Cancer"},{"key":"641_CR21","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","volume":"24","author":"EL Greer","year":"2005","unstructured":"Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410\u20137425. https:\/\/doi.org\/10.1038\/sj.onc.1209086","journal-title":"Oncogene"},{"key":"641_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J et al (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13:890\u2013901","journal-title":"Mol Cancer Ther"},{"key":"641_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","volume":"24","author":"DY Gui","year":"2016","unstructured":"Gui DY, Sullivan LB, Luengo A, Hosios AM, Bush LN, Gitego N, Davidson SM, Freinkman E, Thomas CJ, Vander Heiden MG (2016) Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab 24:716\u2013727","journal-title":"Cell Metab"},{"key":"641_CR24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350\u20131356","journal-title":"Nat Med"},{"key":"641_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","volume":"33","author":"DM Gwinn","year":"2018","unstructured":"Gwinn DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, Simpson DR, Scott AI, Le A, Cowan TM, Ruggero D, Sweet-Cordero EA (2018) Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase. Cancer Cell 33:91\u2013107.e6","journal-title":"Cancer Cell"},{"key":"641_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.trecan.2017.08.006","volume":"3","author":"KM Haigis","year":"2017","unstructured":"Haigis KM (2017) KRAS alleles: the devil is in the detail. Trends Cancer 3:686\u2013697","journal-title":"Trends Cancer"},{"key":"641_CR27","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1126\/science.aaw3472","volume":"363","author":"KM Haigis","year":"2019","unstructured":"Haigis KM, Cichowski K, Elledge SJ (2019) Tissue-specificity in cancer: the rule, not the exception. Science ((1979)) 363:1150\u20131151","journal-title":"Science ((1979))"},{"key":"641_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1021\/pr501191a","volume":"14","author":"DE Hammond","year":"2015","unstructured":"Hammond DE, Mageean CJ, Rusilowicz EV, Wickenden JA, Clague MJ, Prior IA (2015a) Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations. J Proteome Res 14:1535\u20131546","journal-title":"J Proteome Res"},{"key":"641_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1021\/pr501191a","volume":"14","author":"DE Hammond","year":"2015","unstructured":"Hammond DE, Mageean CJ, Rusilowicz EV, Wickenden JA, Clague MJ, Prior IA (2015b) Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations. J Proteome Res 14:1535\u20131546","journal-title":"J Proteome Res"},{"key":"641_CR30","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1091\/mbc.E18-10-0676","volume":"30","author":"FE Hood","year":"2019","unstructured":"Hood FE, Klinger B, Newlaczyl AU, Sieber A, Dorel M, Oliver SP, Coulson JM, Bl\u00fcthgen N, Prior IA (2019) Isoform-specific Ras signaling is growth factor dependent. Mol Biol Cell 30:1108\u20131117","journal-title":"Mol Biol Cell"},{"key":"641_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2017.11.017","volume":"50","author":"M Hornsveld","year":"2018","unstructured":"Hornsveld M, Dansen TB, Derksen PW, Burgering BMT (2018) Re-evaluating the role of FOXOs in cancer. Semin Cancer Biol 50:90\u2013100. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.017","journal-title":"Semin Cancer Biol"},{"key":"641_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","volume":"13","author":"JC Hunter","year":"2015","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD (2015a) Biochemical and structural analysis of common cancer-associated KRAS mutations. Mol Cancer Res 13:1325\u20131335","journal-title":"Mol Cancer Res"},{"key":"641_CR33","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","volume":"13","author":"JC Hunter","year":"2015","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD (2015b) Biochemical and structural analysis of common cancer-associated KRAS mutations. Mol Cancer Res 13:1325\u20131335","journal-title":"Mol Cancer Res"},{"key":"641_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jnci\/djr523","volume":"104","author":"NT Ihle","year":"2012","unstructured":"Ihle NT, Byers LA, Kim ES, Saintigny P, Lee JJ, Blumenschein GR, Tsao A, Liu S, Larsen JE, Wang J et al (2012) Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst 104:228\u2013239","journal-title":"J Natl Cancer Inst"},{"key":"641_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41388-018-0435-5","volume":"38","author":"M Jiang","year":"2019","unstructured":"Jiang M, Xu B, Li X, Shang Y, Chu Y, Wang W, Chen D, Wu N, Hu S, Zhang S et al (2019) O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc\/EZH2 regulatory feedback circuit. Oncogene 38:301\u2013316","journal-title":"Oncogene"},{"key":"641_CR36","doi-asserted-by":"crossref","unstructured":"Kamei Y, Hattori M, Hatazawa Y, Kasahara T, Kanou M, Kanai S, Yuan X, Suganami T, Lamers WH, Kitamura T, Ogawa Y et al (2014) FOXO1 activates glutamine synthetase gene in mouse skeletal muscles through a region downstream of 3\u2019-UTR: possible contribution to ammonia detoxification. Am J Physiol Endocrinol Metab 307:E485\u2013E493","DOI":"10.1152\/ajpendo.00177.2014"},{"key":"641_CR37","doi-asserted-by":"publisher","first-page":"150594","DOI":"10.1016\/j.bbrc.2024.150594","volume":"739","author":"S Karkoutly","year":"2024","unstructured":"Karkoutly S, Takeuchi Y, Mehrazad Saber Z, Ye C, Tao D, Aita Y, Murayama Y, Shikama A, Masuda Y, Izumida Y et al (2024) FoxO transcription factors regulate urea cycle through Ass1. Biochem Biophys Res Commun 739:150594","journal-title":"Biochem Biophys Res Commun"},{"key":"641_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","volume":"21","author":"SA Kerk","year":"2021","unstructured":"Kerk SA, Papagiannakopoulos T, Shah YM, Lyssiotis CA (2021) Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat Rev Cancer 21:510\u2013525","journal-title":"Nat Rev Cancer"},{"key":"641_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr EM, Gaude E, Turrell FK, Frezza C, Martins CP (2016) Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature 531:110\u2013113","journal-title":"Nature"},{"key":"641_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature22359","volume":"546","author":"J Kim","year":"2017","unstructured":"Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B, Bezwada D, Rodriguez-Canales J, Villalobos P, Lin YF et al (2017) CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells. Nature 546:168\u2013172","journal-title":"Nature"},{"key":"641_CR41","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","volume":"2","author":"J Kim","year":"2020","unstructured":"Kim J, Lee HM, Cai F, Ko B, Yang C, Lieu EL, Muhammad N, Rhyne S, Li K, Haloul M et al (2020) The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer. Nat Metab 2:1401\u20131412","journal-title":"Nat Metab"},{"key":"641_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/modpathol.3800789","volume":"20","author":"JH Kim","year":"2007","unstructured":"Kim JH, Kim MK, Lee HE, Cho SJ, Cho YJ, Lee BL, Lee HS, Nam SY, Lee JS, Kim WH (2007) Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol 20:835\u2013842","journal-title":"Mod Pathol"},{"key":"641_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4161\/cbt.12.12.18671","volume":"12","author":"Y-H Ko","year":"2011","unstructured":"Ko Y-H, Lin Z, Flomenberg N, Pestell RG, Howell A, Sotgia F, Lisanti MP, Martinez-Outschoorn UE (2011) Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells. Cancer Biol Ther 12:1085\u20131097","journal-title":"Cancer Biol Ther"},{"key":"641_CR44","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1158\/0008-5472.CAN-07-0108","volume":"67","author":"H Konishi","year":"2007","unstructured":"Konishi H, Karakas B, Abukhdeir AM, Lauring J, Gustin JP, Garay JP, Konishi Y, Gallmeier E, Bachman KE, Park BH (2007) Knock-in of mutant K-RAS in nontumorigenic human epithelial cells as a new model for studying K-RAS \u2013mediated transformation. Cancer Res 67:8460\u20138467","journal-title":"Cancer Res"},{"key":"641_CR45","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1074\/jbc.M110.180661","volume":"286","author":"J-W Lee","year":"2011","unstructured":"Lee J-W, Chen H, Pullikotil P, Quon MJ (2011) Protein kinase A-\u03b1 directly phosphorylates FoxO1 in vascular endothelial cells to regulate expression of vascular cellular adhesion molecule-1 mRNA. J Biol Chem 286:6423\u20136432","journal-title":"J Biol Chem"},{"key":"641_CR46","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41568-018-0076-6","volume":"18","author":"S Li","year":"2018","unstructured":"Li S, Balmain A, Counter CM (2018a) A model for RAS mutation patterns in cancers: finding the sweet spot. Nat Rev Cancer 18:767\u2013777","journal-title":"Nat Rev Cancer"},{"key":"641_CR47","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1158\/1078-0432.CCR-17-3438","volume":"24","author":"S Li","year":"2018","unstructured":"Li S, Liu S, Deng J, Akbay EA, Hai J, Ambrogio C, Zhang L, Zhou F, Jenkins RW, Adeegbe DO et al (2018b) Assessing therapeutic efficacy of MEK inhibition in a KRASG12C-driven mouse model of lung cancer. Clin Cancer Res 24:4854\u20134864","journal-title":"Clin Cancer Res"},{"key":"641_CR48","doi-asserted-by":"publisher","unstructured":"Li X, Zhu H, Sun W, Yang X, Nie Q, Fang X (2021) Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-021-02121-5","DOI":"10.1186\/s12935-021-02121-5"},{"key":"641_CR49","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W (2019) The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res 47:e47","journal-title":"Nucleic Acids Res"},{"key":"641_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37509-3","volume":"9","author":"S Lie","year":"2019","unstructured":"Lie S, Wang T, Forbes B, Proud CG, Petersen J (2019) The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1. Sci Rep 9:1461","journal-title":"Sci Rep"},{"key":"641_CR51","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/bjc.2012.450","volume":"107","author":"Y Lin","year":"2012","unstructured":"Lin Y, Richards FM, Krippendorff B-F, Bramhall JL, Harrington JA, Bapiro TE, Robertson A, Zheleva D, Jodrell DI (2012) Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells. Br J Cancer 107:1692\u20131701","journal-title":"Br J Cancer"},{"key":"641_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"641_CR53","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1126\/science.aaf5171","volume":"353","author":"JR Mayers","year":"2016","unstructured":"Mayers JR, Torrence ME, Danai LV, Papagiannakopoulos T, Davidson SM, Bauer MR, Lau AN, Ji BW, Dixit PD, Hosios AM et al (2016) Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science 353:1161\u20135","journal-title":"Science"},{"key":"641_CR54","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1158\/0008-5472.CAN-20-0622","volume":"81","author":"A Mestre-Farrera","year":"2021","unstructured":"Mestre-Farrera A, Bruch-Oms M, Pe\u00f1a R, Rodr\u00edguez-Morato J, Alba-Castellon L, Comerma L, Quintela-Fandino M, Du\u00f1ach M, Baulida J, Pozo OJ et al (2021) Glutamine-directed migration of cancer-activated fibroblasts facilitates epithelial tumor invasion. Cancer Res 81:438\u2013451","journal-title":"Cancer Res"},{"key":"641_CR55","doi-asserted-by":"publisher","first-page":"e27713","DOI":"10.7554\/eLife.27713","volume":"6","author":"A Muir","year":"2017","unstructured":"Muir A, Danai LV, Gui DY, Waingarten CY, Lewis CA, Vander Heiden MG (2017) Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition. Elife 6:e27713","journal-title":"Elife"},{"key":"641_CR56","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1126\/science.aar5986","volume":"360","author":"A Muir","year":"2018","unstructured":"Muir A, Vander Heiden MG (2018) The nutrient environment affects therapy Nutrient availability affects cancer cell metabolism and therapeutic responses. Science 360:962\u2013963","journal-title":"Science"},{"key":"641_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fonc.2019.01088","volume":"9","author":"C Munoz-Maldonado","year":"2019","unstructured":"Munoz-Maldonado C, Zimmer Y, Medova M (2019) A Comparative analysis of individual RAS mutations in cancer biology. Front Oncol 9:1088","journal-title":"Front Oncol"},{"key":"641_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10401-y","volume":"10","author":"AM Nightingale","year":"2019","unstructured":"Nightingale AM, Leong CL, Burnish RA, Hassan SU, Zhang Y, Clough GF, Boutelle MG, Voegeli D, Niu X (2019) Monitoring biomolecule concentrations in tissue using a wearable droplet microfluidic-based sensor. Nat Commun 10:2741","journal-title":"Nat Commun"},{"key":"641_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep21927","volume":"6","author":"SL Ostrow","year":"2016","unstructured":"Ostrow SL, Simon E, Prinz E, Bick T, Shentzer T, Nagawkar SS, Sabo E, Ben-Izhak O, Hershberg R, Hershkovitz D (2016) Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection. Sci Rep 6:21927","journal-title":"Sci Rep"},{"key":"641_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cell.2006.12.029","volume":"128","author":"JH Paik","year":"2007","unstructured":"Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR et al (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309\u2013323","journal-title":"Cell"},{"key":"641_CR61","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/genes14040933","volume":"14","author":"A Paneque","year":"2023","unstructured":"Paneque A, Fortus H, Zheng J, Werlen G, Jacinto E (2023) The hexosamine biosynthesis pathway: regulation and function. Genes 14:933","journal-title":"Genes"},{"key":"641_CR62","first-page":"356","volume":"2","author":"AM Raczka","year":"2019","unstructured":"Raczka AM, Reynolds PA (2019) Glutaminase inhibition in renal cell carcinoma therapy. Cancer Drug Resist 2:356\u2013364","journal-title":"Cancer Drug Resist"},{"key":"641_CR63","doi-asserted-by":"publisher","first-page":"17179","DOI":"10.1074\/jbc.274.24.17179","volume":"274","author":"G Rena","year":"1999","unstructured":"Rena G, Guo S, Cichy SC, Unterman TG, Cohen P (1999) Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274:17179\u201317183","journal-title":"J Biol Chem"},{"key":"641_CR6","doi-asserted-by":"crossref","unstructured":"Rowe WB, Ronzio RA, Meister A (1969) Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate. Biochemistry 8:2647\u20132680","DOI":"10.1021\/bi00834a065"},{"key":"641_CR64","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1038\/cddis.2014.400","volume":"5","author":"M Shen","year":"2014","unstructured":"Shen M, Liu Z, Li B, Teng Y, Zhang J, Tang Y, Sun S-C, Liu H (2014) Involvement of FoxO1 in the effects of follicle-stimulating hormone on inhibition of apoptosis in mouse granulosa cells. Cell Death Dis 5:e1475","journal-title":"Cell Death Dis"},{"key":"641_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N et al (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101\u2013105","journal-title":"Nature"},{"key":"641_CR66","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305","volume":"358","author":"JB Spinelli","year":"2017","unstructured":"Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC (2017) Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science 358:941\u2013946","journal-title":"Science"},{"key":"641_CR67","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1021\/acs.analchem.7b00396","volume":"89","author":"X Su","year":"2017","unstructured":"Su X, Lu W, Rabinowitz JD (2017) Metabolite spectral accuracy on orbitraps. Anal Chem 89:5940\u20135948","journal-title":"Anal Chem"},{"key":"641_CR68","doi-asserted-by":"publisher","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"44","author":"M Sud","year":"2016","unstructured":"Sud M, Fahy E, Cotter D, Azam K, Vadivelu I, Burant C, Edison A, Fiehn O, Higashi R, Nair KS et al (2016) Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res 44:D463\u201370","journal-title":"Nucleic Acids Res"},{"key":"641_CR69","doi-asserted-by":"publisher","first-page":"e44235","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A (2019) Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8:e44235","journal-title":"Elife"},{"key":"641_CR70","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","volume":"121","author":"DL Trinh","year":"2013","unstructured":"Trinh DL, Scott DW, Morin RD, Mendez-Lago M, An J, Jones SJM, Mungall AJ, Zhao Y, Schein J, Steidl C et al (2013) Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood 121:3666\u20133674","journal-title":"Blood"},{"key":"641_CR71","doi-asserted-by":"crossref","unstructured":"Van Der Heide LP, Hoekman MF, Smidt MP (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380:297\u2013309","DOI":"10.1042\/bj20040167"},{"key":"641_CR72","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ncb2536","volume":"14","author":"KE Van Der Vos","year":"2012","unstructured":"Van Der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, Van Boxtel R, Putker M, Van Zutphen IJ, Mauthe M, Zellmer S, Pals C et al (2012) Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol 14:829\u2013837","journal-title":"Nat Cell Biol"},{"key":"641_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-020-01674-2","volume":"16","author":"D Varshavi","year":"2020","unstructured":"Varshavi D, Varshavi D, McCarthy N, Veselkov K, Keun HC, Everett JR (2020) Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines. Metabolomics 16:51","journal-title":"Metabolomics"},{"key":"641_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01519-y","volume":"8","author":"IP Winters","year":"2017","unstructured":"Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA et al (2017) Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nat Commun 8:2053","journal-title":"Nat Commun"},{"key":"641_CR75","doi-asserted-by":"crossref","unstructured":"Xie L, Ushmorov A, Leith\u00e4 F, Guan H, Steidl C, F\u00e4 J, Pelzer C, Vogel MJ, Maier HJ, Gascoyne RD, M\u00f6ller P, Wirth T (2012) FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 119:3503\u20133511","DOI":"10.1182\/blood-2011-09-381905"},{"key":"641_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","volume":"24","author":"L Yang","year":"2016","unstructured":"Yang L, Achreja A, Yeung TL, Mangala LS, Jiang D, Han C, Baddour J, Marini JC, Ni J, Nakahara R et al (2016) Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth. Cell Metab 24:685\u2013700","journal-title":"Cell Metab"},{"key":"641_CR77","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL et al (2012) Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:656\u201370","journal-title":"Cell"},{"key":"641_CR78","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.celrep.2018.01.051","volume":"22","author":"TL Yuan","year":"2018","unstructured":"Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, Fer N, Strathern LA, Powell K, Smith B et al (2018) Differential effector engagement by oncogenic KRAS. Cell Rep 22:1889\u20131902","journal-title":"Cell Rep"},{"key":"641_CR79","doi-asserted-by":"crossref","unstructured":"Zafra MP, Parsons MJ, Kim J, Alonso-Curbelo D, Goswami S, Schatoff EM, Han T, Katti A, Fernandez MTC, Wilkinson JE, Piskounova E, Dow LE (2020) An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants. Cancer Discov 10:1654\u20131671","DOI":"10.1158\/2159-8290.CD-20-0442"},{"key":"641_CR80","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta Mol Cell Res 1813:1978\u20131986. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.03.010","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"641_CR81","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb2069","volume":"12","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, Wang D, Feng J, Yu L, Zhu WG (2010) Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 12:665\u2013675","journal-title":"Nat Cell Biol"},{"key":"641_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng S, Wang W, Aldahdooh J, Malyutina A, Shadbahr T, Tanoli Z, Pessia A, Tang J (2022) SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteom Bioinforma 20:587\u2013596","journal-title":"Genomics Proteom Bioinforma"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-025-00641-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:37:01Z","timestamp":1779122221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-025-00641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1038\/s44319-025-00641-z","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ARV serves on the scientific advisory board of Chugai Pharmaceuticals (Japan), and is a co-founder of PhoreMost (UK) and Sentinel Oncology (UK).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}